The "POMC Gene Obesity Early-Onset Susceptibility to Genetic Test" is a specialized diagnostic assessment offered by DNA Labs UAE, designed to identify individuals who are genetically predisposed to obesity from an early age due to variations in the POMC gene. The POMC (Proopiomelanocortin) gene is crucial for the regulation of appetite and energy expenditure. Mutations or alterations in this gene can disrupt these processes, leading to early-onset obesity, which is characterized by excessive weight gain during the first years of life.
This genetic test is a valuable tool for individuals who have a family history of obesity or have experienced unexplained weight gain from an early age. By understanding their genetic makeup, individuals can work with healthcare providers to develop personalized prevention or management plans for obesity. The test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the lab for specific genetic markers associated with the POMC gene.
The cost of the test is 4400 AED, reflecting the comprehensive analysis and the specialized technology used to identify the genetic markers. Conducted at DNA Labs UAE, a facility known for its advanced genetic testing services, this test is a step forward in personalized medicine, offering insights that can significantly impact an individual's approach to managing their health in relation to obesity.
The "PPARG Gene Obesity Severe Genetic Test" is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the PPARG gene, which are linked to severe obesity. The PPARG gene plays a crucial role in the regulation of fatty acid storage and glucose metabolism, and mutations in this gene can lead to an increased risk of developing obesity along with associated metabolic conditions. This test is particularly useful for individuals who have a family history of severe obesity or related metabolic disorders and are seeking a genetic explanation for their condition.
The procedure involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the laboratory to detect any genetic variations in the PPARG gene that might contribute to obesity. Understanding whether these genetic factors are present can be vital for developing personalized treatment plans and preventive measures.
The test is priced at 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify and interpret genetic variations. Conducted at DNA Labs UAE, a facility known for its state-of-the-art genetic testing services, clients are assured of reliable results that can significantly impact their health management strategies. This test is an important step for individuals looking to understand their genetic predisposition to obesity and take proactive steps towards managing their health.
The SLC6A14 gene plays a critical role in obesity susceptibility, making it a significant focus for individuals concerned about their weight management and health. The SLC6A14 gene encodes a protein involved in amino acid transport, which is crucial for maintaining the body's metabolism and energy balance. Variations or mutations in this gene have been linked to an increased risk of obesity, making it a target for genetic testing.
DNA Labs UAE offers a specialized genetic test aimed at identifying variations in the SLC6A14 gene that may predispose individuals to obesity. This test is particularly beneficial for those seeking a deeper understanding of their genetic makeup in relation to obesity, enabling them to make informed decisions about their lifestyle and health management strategies.
The test is priced at 4400 AED and is conducted in a state-of-the-art facility by experienced professionals. By opting for this test, individuals can gain valuable insights into their genetic predisposition to obesity, which in turn can guide them in tailoring their diet, exercise, and overall lifestyle to mitigate this risk.
The SLC4A1 Gene Ovalocytosis Genetic Test is a specialized diagnostic procedure designed to identify mutations in the SLC4A1 gene, which are associated with hereditary ovalocytosis, a rare blood disorder. This condition is characterized by the presence of oval-shaped red blood cells, which can lead to various symptoms, including anemia, jaundice, and increased susceptibility to certain infections. The test involves collecting a DNA sample, typically through a blood draw, and analyzing it for specific genetic alterations in the SLC4A1 gene.
Conducted at DNA Labs UAE, a leading facility in genetic testing, this test offers a comprehensive approach to diagnosing hereditary ovalocytosis. The cost of the test is set at 4400 AED, reflecting the advanced technology and expertise required to accurately identify the genetic mutations associated with this condition. Through this test, individuals can gain valuable insights into their genetic makeup, enabling informed decisions about their health and the management of the disorder.
The CTRC Gene Pancreatitis Genetic Test is a specialized diagnostic procedure offered at DNA Labs UAE, designed to detect mutations in the CTRC gene that are associated with an increased risk of developing pancreatitis. Pancreatitis is an inflammation of the pancreas that can lead to a variety of health complications, and genetic factors play a significant role in the predisposition to this condition. The CTRC gene encodes for the enzyme chymotrypsin C, which is involved in the digestion of proteins in the digestive system. Mutations in this gene can disrupt the normal function of the enzyme, leading to the accumulation of digestive enzymes and the subsequent damage to the pancreas.
The test is conducted using a blood sample from the patient, which is then analyzed using advanced genetic sequencing techniques to identify any mutations in the CTRC gene. This test is particularly recommended for individuals with a family history of pancreatitis or those who have experienced recurrent episodes of the condition without a clear cause.
At DNA Labs UAE, the cost of the CTRC Gene Pancreatitis Genetic Test is 4400 AED. This cost includes the collection of the sample, the genetic analysis, and a comprehensive report that explains the results. The report also provides guidance on the next steps, including potential lifestyle adjustments or medical interventions that may be recommended based on the findings. The test offers valuable insights for individuals at risk, enabling them to take proactive measures in managing their health and preventing the onset or progression of pancreatitis.
The PRSS1 Gene Pancreatitis Genetic Test is a specialized diagnostic procedure designed to identify mutations in the PRSS1 gene, which is known to be a key factor in the development of hereditary pancreatitis. This condition is characterized by recurrent episodes of pancreatic inflammation, which can lead to chronic pancreatitis and increase the risk of pancreatic cancer over time. By analyzing an individual's DNA, this test can determine whether they carry genetic variations associated with an increased risk of developing pancreatitis.
Performed at DNA Labs UAE, a leading facility in genetic testing and analysis, the test provides crucial information for individuals with a family history of pancreatitis or those experiencing symptoms related to the condition. Early detection through genetic testing can enable proactive management strategies, including lifestyle adjustments and medical interventions, to mitigate the impact of the disease and improve quality of life.
The cost of the PRSS1 Gene Pancreatitis Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to accurately identify the presence of PRSS1 gene mutations. Clients can expect a detailed report of their test results, along with guidance and recommendations for next steps if a genetic predisposition to pancreatitis is identified.
The SPINK1 Gene Pancreatitis Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the SPINK1 gene, which are associated with an increased risk of developing pancreatitis. Pancreatitis is an inflammation of the pancreas that can lead to a range of health issues, from acute episodes of pain to chronic digestive problems and even diabetes. Mutations in the SPINK1 gene can lead to a form of pancreatitis that may be inherited, making this test particularly valuable for individuals with a family history of the condition.
The test is priced at 4400 AED and involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory to detect any genetic alterations in the SPINK1 gene. Results from this test can provide crucial information for individuals and families regarding their risk of developing pancreatitis, allowing for informed decisions about lifestyle, diet, and potential preventative treatments. Conducted in the state-of-the-art facilities of DNA Labs UAE, this genetic test represents a key step towards personalized medicine in the management and prevention of pancreatitis.
The CPA1 Gene Pancreatitis Chronic Early Onset Genetic Test is a specialized genetic screening offered by DNA Labs UAE, designed to identify mutations in the CPA1 gene, which are linked to an increased risk of developing chronic pancreatitis at an early age. Chronic pancreatitis is a long-term inflammation of the pancreas that can lead to irreversible damage and a host of digestive and metabolic problems. The CPA1 gene encodes the enzyme carboxypeptidase A1, which plays a crucial role in the digestion of proteins. Mutations in this gene can disrupt the enzyme's function, leading to the premature activation of digestive enzymes within the pancreas and causing tissue damage.
This test is particularly valuable for individuals with a family history of pancreatitis or those experiencing symptoms suggestive of the disease, as early detection can facilitate timely intervention and management strategies to mitigate complications. Conducted in the state-of-the-art facilities of DNA Labs UAE, the test ensures high accuracy and reliability. The cost of the CPA1 Gene Pancreatitis Chronic Early Onset Genetic Test is 4400 AED, reflecting the sophisticated technology and expert analysis involved in identifying the genetic markers associated with this condition.
The NPHS1 gene nephrosis Finnish type genetic test is a specialized diagnostic examination designed to identify mutations in the NPHS1 gene, which are known to cause congenital nephrotic syndrome of the Finnish type (CNF). This condition is a rare genetic disorder primarily affecting the kidneys and characterized by significant protein loss in the urine, leading to swelling and a range of other health issues. The test is crucial for early detection and management of the condition, particularly in populations where the mutation is prevalent or in families with a history of the disease.
Conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing capabilities, the test involves collecting a DNA sample, typically through a blood draw or a cheek swab, and analyzing it for specific genetic alterations in the NPHS1 gene. The outcome of this test can provide essential information for the diagnosis, treatment planning, and genetic counseling of affected individuals and their families.
The cost of the NPHS1 gene nephrosis Finnish type genetic test at DNA Labs UAE is 4400 AED. This price reflects the comprehensive nature of the test, including the sophisticated technology and expertise required to accurately identify the genetic mutations associated with the condition. For families and individuals considering this test, it's an investment in obtaining a crucial understanding of their genetic health, potentially leading to early intervention and better management of congenital nephrotic syndrome of the Finnish type.
The NPHS2 Gene Nephrotic Syndrome Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the NPHS2 gene, which are known to cause steroid-resistant nephrotic syndrome (SRNS). This condition is characterized by significant proteinuria, hypoalbuminemia, and edema, and it does not respond to standard steroid treatments, making genetic testing crucial for accurate diagnosis and management. The NPHS2 gene encodes podocin, a protein essential for the proper function of the glomeruli in the kidneys. Mutations in this gene can disrupt kidney function, leading to SRNS.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, this test offers a comprehensive analysis for individuals suspected of having SRNS, especially when there is a family history of kidney diseases or when the condition does not improve with conventional treatments. The test is priced at 4400 AED, reflecting the intricate technology and expertise required to accurately detect mutations in the NPHS2 gene.
Upon completion, the results can provide valuable insights into the genetic underpinnings of the nephrotic syndrome in the patient, guiding healthcare providers in tailoring a more effective treatment plan. This may include adjustments in medication, consideration of genetic counseling for the family, and in some cases, preparation for kidney transplantation. Given the complexity and the potential severity of SRNS, the NPHS2 Gene Nephrotic Syndrome Genetic Test represents a critical step towards personalized medicine in nephrology.
